IP Verse

Competitive analysis in Antibodies industry

Latest patents granted in the Antibodies industry

Patent:
EP3218406
Grant Date:
Oct 2, 2024
Title:
Binding Molecules Specific For Cd73 And Uses Thereof
Applicant:
MEDIMMUNE LIMITED
Patent:
EP2634243
Grant Date:
Jul 24, 2024
Title:
Improved Process For The Culturing Of Cells
Applicant:
DPX HOLDINGS B.V.
Patent:
EP3152234
Grant Date:
Jun 26, 2024
Title:
Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T Lymphocytes
Applicant:
CELLVAX
Patent:
EP3296395
Grant Date:
Jun 19, 2024
Title:
Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Patent:
EP3622813
Grant Date:
Jun 19, 2024
Title:
Animal Models And Therapeutic Molecules
Applicant:
KYMAB LIMITED
Patent:
EP3167888
Grant Date:
May 1, 2024
Title:
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
Applicant:
ALEXION PHARMACEUTICALS, INC.
Patent:
EP3294770
Grant Date:
Mar 20, 2024
Title:
Therapeutic And Diagnostic Methods For Cancer
Applicant:
F. HOFFMANN-LA ROCHE AG
Patent:
EP4058148
Grant Date:
Mar 13, 2024
Title:
Dosing Regimen For Anti-Bcma Agents
Applicant:
AMGEN INC.
Patent:
EP2637670
Grant Date:
Mar 13, 2024
Title:
Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains
Applicant:
AMGEN RESEARCH (MUNICH) GMBH
Patent:
EP3400291
Grant Date:
Feb 28, 2024
Title:
Engineered Virus
Applicant:
REPLIMUNE LIMITED

Top patents facing oppositions in Antibodies industry

Patent:
EP3177645
Grant Date:
Feb 17, 2021
Title:
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
Applicant:
LINDHOFER, HORST, DR.
Oppositions:
60
Patent:
EP3337812
Grant Date:
Apr 28, 2021
Title:
Method For The Reduction Of Host Cell Proteins In Affinity Chromatography
Applicant:
GENENTECH, INC.
Oppositions:
56
Patent:
EP2261230
Grant Date:
May 10, 2017
Title:
Protein Purification Method
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Oppositions:
35
Patent:
EP2462158
Grant Date:
Jan 10, 2018
Title:
Method To Improve Virus Removal In Protein Purification
Applicant:
F.HOFFMANN-LA ROCHE AG
Oppositions:
33
Patent:
EP3616720
Grant Date:
Feb 17, 2021
Title:
Pharmaceutical Composition For Cancer Treatment
Applicant:
OSAKA UNIVERSITY
Oppositions:
30
Patent:
EP2646470
Grant Date:
Mar 1, 2017
Title:
Low Affinity Blood Brain Barrier Receptor Antibodies And Uses Therefor
Applicant:
F. HOFFMANN-LA ROCHE AG
Oppositions:
24
Patent:
EP2780375
Grant Date:
Sep 11, 2019
Title:
Binding Molecules For Bcma And Cd3
Applicant:
AMGEN INC.
Oppositions:
24
Patent:
EP2604625
Grant Date:
Jun 28, 2017
Title:
Generation Of Binding Molecules
Applicant:
MERUS N.V.
Oppositions:
24
Patent:
EP3152234
Grant Date:
Jun 26, 2024
Title:
Antibody Which Is Directed Against Galectin-9 And Is An Inhibitor Of The Suppressor Activity Of Regulatory T Lymphocytes
Applicant:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.)
Oppositions:
24
Patent:
EP2780374
Grant Date:
Aug 21, 2019
Title:
Binding Molecules For Bcma And Cd3
Applicant:
AMGEN INC.
Oppositions:
21

Top companies filing oppositions in Antibodies industry

Company:
STRAWMAN LIMITED
Total oppositions filed:
59
Company:
REGENERON PHARMACEUTICALS, INC.
Total oppositions filed:
54
Company:
JAMES POOLE LIMITED
Total oppositions filed:
48
Company:
MAIWALD GMBH
Total oppositions filed:
31
Company:
MARGARET DIXON LIMITED
Total oppositions filed:
27
Company:
KONIG SZYNKA TILMANN VON RENESSE
Total oppositions filed:
27
Company:
NEUEFEIND, REGINA
Total oppositions filed:
22
Company:
HOFFMANN EITLE
Total oppositions filed:
22
Company:
PFIZER INC.
Total oppositions filed:
21
Company:
GENMAB A/S
Total oppositions filed:
17

Top companies facing oppositions in Antibodies industry

Company:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Total facing oppositions:
114
Company:
F. HOFFMANN-LA ROCHE AG
Total facing oppositions:
102
Company:
GENENTECH, INC.
Total facing oppositions:
75
Company:
F.HOFFMANN-LA ROCHE AG
Total facing oppositions:
55
Company:
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Total facing oppositions:
47
Company:
AMGEN INC.
Total facing oppositions:
40
Company:
BRISTOL-MYERS SQUIBB COMPANY
Total facing oppositions:
31
Company:
NOVARTIS AG
Total facing oppositions:
31
Company:
REGENERON PHARMACEUTICALS, INC.
Total facing oppositions:
30
Company:
KYMAB LIMITED
Total facing oppositions:
28

Need more information?

Feel free to send us a message here and we will get back to you